Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials

Sandra P. D'Angelo, Michelle R. Mahoney, Brian A. Van Tine, James Atkins, Mohammed M. Milhem, Balkrishna N. Jahagirdar, Cristina R. Antonescu, Elise Horvath, William D. Tap, Gary K. Schwartz, Howard Streicher

Research output: Contribution to journalArticlepeer-review

284 Scopus citations

Fingerprint

Dive into the research topics of 'Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials'. Together they form a unique fingerprint.

Medicine & Life Sciences